Contera Pharma A/S clinical trials
Acquired by Bukwang Pharmaceutical, Nov 24, 2014 · source ↗
The registry lists 2 studies whose lead sponsor is Contera Pharma A/S. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2024.
Before and after it joined Bukwang Pharmaceutical
- First submitted before Contera Pharma A/S became part of Bukwang Pharmaceutical
- 0
- First submitted after Contera Pharma A/S became part of Bukwang Pharmaceutical
- 2
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Contera Pharma A/S1 study
- Contera Pharma1 study
Something wrong with this grouping? Tell us on the Bukwang Pharmaceutical page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Bukwang Pharmaceutical studies →
- Open-Label Extension Study of ASTORIATerminatedNCT05516875Phase 2
Sponsor listed in the registry: Contera Pharma A/S · First submitted after Contera Pharma A/S became part of Bukwang Pharmaceutical
- A Study in Parkinson's Disease in Patients With Moderate to Severe DyskinesiaCompletedNCT03956979Phase 2
Sponsor listed in the registry: Contera Pharma · First submitted after Contera Pharma became part of Bukwang Pharmaceutical